TP53 and breast cancer: We employed three widely used cell systems: the breast cancer cell line MCF-7, the osteosarcoma cell line U2OS, and the hTERT-immortalized noncancerous retina-pigmented epithelium cell line RPE-1—all of which possess wild-type p53.